Maze Therapeutics - Entities Affiliated With Arch Venture Partners and Related Entities Beneficially Owned 11.8% of Common Shares Prior to Offering
Maze Therapeutics - 與Arch Venture Partners及相關實體相關的公司在發行前持有11.8%的普通股。
Maze Therapeutics - Entities Affiliated With Arch Venture Partners and Related Entities Beneficially Owned 11.8% of Common Shares Prior to Offering
Maze Therapeutics - 與Arch Venture Partners及相關實體相關的公司在發行前持有11.8%的普通股。
使用瀏覽器的分享功能,分享給你的好友吧